Is It Really a Mugwort Patch? Checking Formula and Product Identity

13. Read the botanical preparation before comparing percentages

A statement such as “contains mugwort extract” leaves several quantities unresolved. It may name the purchased ingredient, the extract within that ingredient, or a botanical input used during production. Those quantities should not be collapsed into one percentage. For a balm or coated patch, the buyer needs to connect the botanical material to the preparation actually incorporated and then to the finished product.

Two European Medicines Agency sources explain this distinction in the context of herbal medicines: the declaration guideline, Revision 1, and the quality guideline, Revision 3. At the time of this source check, EMA listed the 2010 declaration guideline as the current effective version and a 2026 Revision 2 as a draft with consultation closed. The 2022 quality guideline was listed as current effective. These documents are medicinal frameworks. They help explain technical vocabulary here; they do not determine the category, authorization or label compliance of any reference balm or patch. EMA declaration guideline status; EMA herbal-quality guideline status.

Material, preparation and final formula are successive descriptions

The declaration guideline distinguishes a herbal substance from a herbal preparation. The substance is the identified plant material; the preparation results from processing such as extraction, distillation, expression or other specified treatments. Its botanical identity still matters, but the process adds information that the plant name cannot convey. A powder, a tincture and an essential oil are not three interchangeable ways to write the same ingredient.

The final balm or patch adds another level. It can contain that preparation alongside its own carrier, adhesive, water, oils or other components. A percentage of a preparation in the finished formula therefore describes a different relationship from the ratio used to make that preparation. A supplier’s statement about one relationship does not fill the field for another.

Start a comparison with the full chain: identified plant material and part; named preparation and physical state; relevant processing description; excipients included in the supplied preparation; quantity incorporated into the finished formulation; and the basis of that quantity. If the file stops at “mugwort”, retain the shorter declaration faithfully and leave the remaining fields open. Do not reconstruct an extract specification from a familiar product name.

What “genuine” or “native” means in an extract file

In this technical terminology, the genuine or native preparation is considered without added excipients. It is not an authenticity award, an organic claim or a statement that one supplier is more trustworthy. The definition also notes that soft and liquid genuine preparations may contain variable amounts of extraction solvent. Thus “native” should not be silently translated as dry, solvent-free or chemically pure. Declaration guideline, definitions.

A commercial extract ingredient can contain the genuine preparation and added technological ingredients. The mass of the purchased ingredient may consequently be larger than the mass of its genuine extract fraction. To interpret a stated percentage, ask whether it includes those excipients. This is a question about the calculation basis, not a suggestion that the presence of a carrier makes the ingredient misleading or unsuitable.

Do not confuse this carrier with the final balm’s base. A technological carrier supplied within a botanical extract and an oil or adhesive used to make the finished product occupy different positions in the record. They may both be relevant to a complete composition account, but one cannot be deducted from the other without an actual formulation and quantities.

The extraction ratio is an input-to-preparation relationship

The drug-extract ratio, usually abbreviated DER, relates the quantity of herbal substance used to the quantity of preparation obtained. DER genuine refers specifically to the genuine preparation. The quantities on the two sides of the colon need their stated basis. A number describing the botanical input relative to extract is not a percentage of mugwort in a finished balm, nor a measurement of how much crosses skin.

The declaration guideline includes ranges because a preparation can be described by a range of input-to-output relationships rather than a single unexplained marketing number. For comparison, retain the range, identify the material and preparation to which it belongs, and keep the extraction solvent alongside it. Removing the range to make the display shorter changes the information the source provides.

Nor does a larger numerical ratio alone establish greater clinical strength. It does not identify the entire chemical composition or the final application amount. Two preparations with different plants, plant parts or processes do not become comparable simply because both are described as “10:1”. The reference mugwort listings do not provide verified DER values; this explanation does not supply them.

A published calculation shows why the denominator matters

EMA’s declaration guideline gives an illustrative valerian-root dry-extract example. It describes 200 mg of an extract ingredient containing 80% genuine extract and 20% other excipients. The genuine extract quantity is therefore 160 mg. With the stated genuine ratio of 3–6:1, the example expresses the corresponding botanical input as 480–960 mg of valerian root. These values belong to that illustrative declaration, not to a mugwort product. Declaration guideline, section 6.2.3, example a.

The calculation separates three masses: supplied ingredient, genuine extract and equivalent starting material. None is the amount absorbed by a patient. Applying the ratio to the full 200 mg, without first accounting for the genuine fraction, would answer a different and incorrect question for that example. The lesson for a balm or patch specification is to name the calculation basis before multiplying anything.

It would also be incorrect to transfer the example’s root, solvent, ratio or excipient fraction to mugwort. The example is useful because its relationships are explicit. A real mugwort preparation needs its own declaration and supporting specification, not a set of numbers borrowed from a worked example about another plant.

A marker result is not automatically a therapeutic claim

The herbal-quality guideline distinguishes constituents with known therapeutic activity, active markers and analytical markers. It describes standardised preparations adjusted to a defined content of constituents with known therapeutic activity, quantified preparations adjusted to a specified range of active markers, and other preparations using analytical markers for control. The categories have defined meanings in that medicinal framework; they are not synonyms for “premium extract”. Quality guideline, section 3.1.

An analytical marker can be chosen for analytical control independently of therapeutic activity. A report showing that marker’s content may therefore answer an identity or consistency question without establishing pain relief. Ask what the marker is, why it was selected, which specification it belongs to and what conclusion the method supports. Do not turn a chromatographic peak or a content result into an efficacy statement by changing its heading.

The distinction also matters when comparing batches. If a supplier calls an extract standardised, ask for the actual defined constituent and adjustment basis. If it calls the result quantified, ask what range and marker it means. Preserve the supplier’s exact technical category when supported, or record that the word has not yet been explained. Neither an undefined “standardized” label nor an isolated assay number establishes equivalence to a preparation used in a clinical trial.

Extraction solvent and finished-product composition need separate fields

The declaration framework identifies the extraction solvent or solvent mixture and the preparation’s physical state. This tells the reader about manufacture of the preparation. It does not, by itself, tell the reader the complete solvent composition in the finished topical product or a measured residual-solvent concentration.

In a multi-stage file, preserve the role of each entry: solvent used to make the preparation; any solvent remaining as part of the supplied preparation; additional liquid used to formulate the balm, liniment or adhesive; and any result specifically measuring a residual substance. Where one of these is relevant but unknown, leave that field unresolved rather than translating an extraction description directly into a finished-product percentage.

Use the declaration to compare the right objects

A usable identity comparison should now distinguish a plant-name match from a preparation match and a finished-product match. The same species and part do not establish the same extract. The same extract name does not establish the same excipient fraction. The same incorporated percentage does not establish the same applied amount, delivery or clinical result.

For the reference listings, the remaining request is narrow: obtain the selected preparation’s identity and composition basis, then reconcile that information with the actual formula and current label. This does not require publishing a supplier’s confidential manufacturing recipe. It requires sufficient controlled information for the relevant buyer decision and product obligations, with private technical details kept in the appropriate file.

14. Identity continues after the plant has been named

A Latin name on a balm label answers only one part of the identity question. It does not show how the harvested plant was identified, whether a supplied extract came from that material, or whether the declared extract belongs to the formula now being offered. The practical task is to connect those objects without treating one document as a description of all of them.

The EMA’s final 2025 GACP guideline, sections 4, 7 and 8, explains the upstream part of this problem. Its scope is herbal substances used to prepare herbal medicinal products. It is used here to explain identity records; this collection has not established the classification or GACP compliance of the reference finished products.

Identification at collection and identification on a label are different records

The guideline expects collectors to know the plant’s identifying characteristics and habitat, distinguish it from botanically related or visually similar species, recognise diseased plants or plant parts, and understand relevant collection and processing practices. Where adequate knowledge is lacking, local supervision and verification of training and documentation are described. That is a description of the identification process, rather than a recommendation to identify a raw herb from a retail product photograph.

For a mugwort-related patch, an upstream record might therefore concern the harvested botanical material while the retail label concerns a coated article containing a preparation. Neither record should be made to answer the other’s question. The label can declare a botanical name without showing the collection record. A collection record can establish which material was collected without establishing the full composition of a later adhesive layer.

When the preparation is an extract, ask which input record is linked to the supplied extract lot. When the extract is incorporated into a balm or coating, ask which formula version identifies it. These are proposed evidence links, not a claim that a particular reference product has already supplied such records. If a link is missing, identify the missing link precisely; do not replace it with the claim that the product contains no mugwort.

Propagation information can be more specific than the common name

For seeds and vegetative propagation material, the guideline includes genus, species, variety, cultivar or chemotype, and origin among the identification considerations. It also addresses evaluation of propagation-material suppliers and documentation of changes that can affect quality. This explains why two records that both use a common plant name need not contain the same level of identity information.

It does not mean every public topical-product listing must print every possible botanical subdivision. The question is which detail is relevant to the material actually specified, and whether that detail remains consistent in the private supply record. A public listing that names the species but says nothing about a cultivar leaves that field unknown; it does not prove that the wrong cultivar was used or that cultivar selection was relevant.

Keep the declared plant part alongside the botanical name. The guideline addresses control of different species, varieties and plant parts throughout production, rather than identification at only one point. A leaf declaration should not silently turn into an unspecified whole-plant declaration when information is copied from a source record into an extract description or a finished-product brief.

Environmental examples are reasons to check, not findings in these products

The collector-training section discusses contamination from the immediate environment and from co-collected poisonous weeds. Examples include pyrrolizidine alkaloids, tropane alkaloids, polycyclic aromatic hydrocarbons and heavy metals. They are examples in a general guideline. This collection has not detected them in the reference mugwort products, and the list is not a report that those products contain them.

A useful reading separates the hazard considered, the material to which it relates, the evidence actually obtained and any applicable acceptance criterion. A field-risk assessment is not the same as a finished-balm analytical result. A test on one constituent is not a complete botanical identity assessment. Where a supplier provides a report, retain the actual specimen and method scope rather than changing “tested for” into “proved free of”.

The result of this identity-chain review is a clearer description of what is known about the supplied material. It does not supply a harvest optimum, a universal contaminant limit, a therapeutic effect or a safe application instruction. Those conclusions require their own relevant product evidence.

15. A microscope image answers a different identity question from an ingredient list

A finished-product image, a botanical declaration and a laboratory micrograph can all be labelled “product information”, but they do not establish the same facts. Keeping their roles separate prevents a visible particle from becoming an invented ingredient identity or a smooth-looking balm from becoming proof that every constituent is dissolved.

The FDA’s final 2026 Q3 guidance, section III, items 2–4, describes phase and structural characterisation in the context of topical drugs submitted in ANDAs. The following explains how to read those kinds of records. No microscopy, particle analysis or polymorph analysis of the reference botanical products has been performed by this collection.

Look for the specimen and preparation, not just the picture

The guidance discusses representative high-resolution micrographs at multiple magnifications, with detailed sample-preparation information. In that context, suitable images can help differentiate a single-phase product, a multiphase product such as an emulsion, or a formulation with suspended active ingredient. The magnification and preparation are part of the evidence, rather than decoration beneath the image.

The absence of visible undissolved particles in appropriate images may support an interpretation that the active ingredient is dissolved. It does not identify every molecule in an unknown herbal preparation, establish the botanical species or prove an unlimited absence of particles. A commercial photograph is not such a micrograph, and a photograph of an ingredient is not an analysis of the finished formula.

If white or dark particles appear in a sample, do not name them as herb, active ingredient, filler or contaminant from appearance alone. Preserve the observation and identify what analytical work, if any, actually determined their nature. The distinction remains important even when the seller has provided a complete ingredient declaration.

A size distribution is more than an average

For relevant multiphase products, the guidance discusses particle-size distribution and crystal habit, and emulsion globule-size distribution where applicable. It asks for full distribution profiles for relevant samples. A single average cannot show the same information as the distribution from which it was calculated.

For emulsions, the type of emulsion is another separate determination. The source gives examples of appropriate techniques involving a water-soluble dye and microscopic assessment, or dilution and an electrical assessment. They are examples of laboratory characterisation, not instructions for a buyer to diagnose the formulation at home.

When comparing reports, keep the actual material and method attached to each result. A globule-size result for one formula is not automatically a particle-size specification for a different balm. Nor can an extract’s declared particle size be substituted for a measurement of the finished semisolid without evidence that the measurement concerns the same object.

Do not turn missing evidence into a physical conclusion

The source also discusses characterising the polymorphic forms of suspended active ingredient within a drug product. It warns that an absence of evidence of polymorphs does not establish that they do not exist. Whether this kind of assessment is relevant to a particular constituent and formulation must be established; the presence of a herbal mixture does not provide that answer.

Botanical identity, a chemical marker assay and physical-structure characterisation therefore remain distinct. One asks which plant material is declared or identified, another asks about a measured chemical constituent, and another describes the arrangement of matter in the tested formulation. A well-labelled picture cannot perform all three tasks.

16. Read a botanical fingerprint as an identity record

When a buyer asks whether a balm or patch really contains the named botanical material, a chromatogram can look like a decisive answer. Its value depends on what was tested and what the method can distinguish. A peak on a page is not automatically a species identification or a measurement of the whole herbal preparation.

The EMA specifications guideline, Revision 3, sections 3.1.1, 5.1, 5.2 and 5.4, describes botanical and phytochemical identification in herbal medicinal products. Its medicinal scope matters: the methods explain evidence types here without establishing the regulatory category or analytical compliance of a reference product.

The whole plant and the finished preparation offer different features

Macroscopic and microscopic botanical characters can help identify plant material and distinguish potential substitutes or adulterants. After processing into an extract and incorporation into a balm or adhesive layer, the available identification features are different. A photograph of a leaf and an analysis of the finished preparation should therefore retain their respective specimen identities.

The guideline describes phytochemical characterisation using analytical information such as chromatographic fingerprints. It treats the herbal substance or preparation as a complex, multicomponent active substance in the medicinal framework. Selected characteristic constituents can support a fingerprint for identity and consistency; the fingerprint is not a claim that one peak represents every component.

Ask what makes the identification specific

For herbal preparations and finished herbal medicines, the guideline says identification based solely on chromatographic retention time is not regarded as specific. It gives examples of combinations of chromatographic tests or combined techniques that may be acceptable, including HPLC with diode-array detection, HPLC/MS and GC/MS. These names describe analytical approaches, not tests performed by this collection.

A report should therefore explain the identification basis rather than simply display a familiar instrument abbreviation. Which material and preparation were examined? What comparison or reference was used? Which method and result support the stated conclusion? Does the work concern the raw botanical input, an extract or the actual finished formula? An answer for one object should not be relabelled as an answer for another.

A fingerprint and an assay remain complementary

A characteristic fingerprint can help assess identity and a pattern of constituents. An assay quantifies a defined constituent or another justified quantity. A marker concentration does not replace the whole identity comparison, and a visually similar fingerprint does not itself state how much extract was incorporated into the balm.

For a combination product, the finished fingerprint must also be interpreted with the contributions of its components in mind. The six reference products contain different declarations and combinations; they should not be assigned one common “mugwort fingerprint” merely because the commercial category shares that word.

The practical outcome is a narrower, checkable claim: the stated specimen was examined by the stated method and the report supports the stated identification conclusion. That can improve an authenticity review without becoming a clinical-effect claim, a certification of every batch or an unqualified statement that all possible substitutes have been excluded.

17. Identify the reference material behind the result

The word “reference” can mean a product chosen for discussion, a plant specimen, an extract used for comparison or a defined chemical standard. Those objects have different roles. The six commercial reference products in this collection are examples for reading public information; they are not analytical reference standards.

Section 3.7 of the EMA herbal specifications guideline explains reference materials for identity, purity testing and assignment of content. It includes a botanical sample, a preparation such as an extract or tincture, or a chemically defined substance such as a marker or known impurity. The selected reference needs to be suitable for its intended analytical purpose.

A material can be suitable for one purpose without settling another

The guideline notes that pharmacopoeial reference standards are described for a dedicated purpose and demonstrated suitable for the indicated use. A reference selected for identifying a constituent should not automatically be presented as establishing the quantitative content of the entire botanical preparation. A reference for a known impurity is not a complete authenticity standard for the plant.

When reviewing a mugwort-related report, identify the reference by its actual documented role. Was it used to compare botanical characters, a chromatographic pattern or a measured constituent? Is that role the one needed for the conclusion on the report? Keeping these questions explicit prevents the word “standard” from supplying more authority than the analysis contains.

Plant specimens and chemical references preserve different information

The guideline discusses availability of a herbarium specimen where the herbal substance is not described in a relevant pharmacopoeia, with a whole plant or an appropriate part where a whole specimen is impractical. That concerns an authenticated botanical record. It is distinct from a small vial of a chemical reference or a retained finished balm.

This does not establish a herbarium requirement for every reference topical product. Its value here is explanatory: an upstream plant record, a preparation reference and a finished-product sample preserve different information. A buyer asking about the botanical source should not be told that an unrelated finished-product photograph is the same evidence.

Read the result at the reference’s actual scope

A useful analytical record links the test specimen, reference material, procedure, result and conclusion. If one element is unknown, preserve the uncertainty instead of replacing it with a broad “laboratory verified” statement. A laboratory’s name alone does not identify the reference used or the question answered.

Nor does a chemical reference supply evidence about pain relief, an organic scheme, a wear period or an individual’s tolerance. Those are separate questions. Within an identity dossier, its contribution is the specific analytical comparison or assigned content that the method and reference support.

18. A marker calculation needs the actual preparation batch

The earlier declaration section separates an extract ingredient, its genuine fraction and its botanical input. A marker assay adds another relationship. It measures the selected constituent or group under an analytical method; calculating an amount of preparation from that result requires the appropriate content basis.

Section 3.1.3 of the EMA herbal specifications guideline discusses using batch-specific marker content to quantify the herbal preparation as active substance in a finished herbal medicine. It also requires justification of the marker’s purpose and suitable analytical control. This is an explanation of that evidence relationship, not an assay result for a reference balm.

Keep the numerator and denominator on the same basis

Consider an arithmetic illustration only. Suppose a preparation is measured to contain 2% of a selected marker by mass, and the finished composition contains 0.1% of that marker by mass. If the marker comes only from that preparation, the relevant content bases match and the analytical relationship is valid, dividing 0.1 by 2 gives a preparation mass fraction of 0.05, or 5%.

The assumptions are part of the example. It is not a verified method, formula or mugwort result. If another component contributes the marker, if one percentage concerns a dry basis and the other an as-supplied basis, or if the finished-product measurement does not validly represent the marker content, the simple division cannot supply the claimed preparation amount.

The preparation in the calculation must also be the preparation whose marker content is used. Substituting a generic literature concentration for an actual batch-specific value changes the evidence. A result for another plant, extract method or supplied ingredient is not automatically a suitable denominator.

Do not confuse adjustment categories with a potency ranking

The declaration section explains the guideline’s standardised, quantified and other preparation categories. For an actual report, retain the relevant declared category and marker role rather than translate every controlled percentage into “standardised mugwort”. An analytical marker can serve control purposes without being the constituent responsible for a therapeutic effect.

The specifications guideline also distinguishes ranges or declared-content criteria from variation relative to an initial batch-specific result. These are different reference values. A result can be close to an initial measurement while answering a different question from conformity to a declared-content range. Preserve the actual criterion, basis and stage instead of recording only “within tolerance”.

Report the supported quantity

A clear evidence note names the preparation and lot, the marker and its role, the measured content in the preparation, the finished-product result, the calculation basis and the supported conclusion. If the source gives only a marker result, retain it as a marker result. Do not manufacture a full extract percentage from missing information.

Even a valid preparation-content calculation is not the amount released from a patch, absorbed through skin or responsible for pain relief. Those quantities concern different evidence. Keeping them separate allows the assay to be useful without asking it to prove more than it measured.

19. Read an extract’s physical test on its own measurement basis

A preparation file may report water, loss on drying, particle size or an organoleptic description. These entries add information to the botanical name, but each describes a particular property. They should not be combined into a general assertion that an extract is pure, stronger or clinically effective.

The EMA specifications guideline, sections 5.1 and 5.2, separates characteristics of herbal substances from characteristics of preparations. This distinction helps a buyer recognise whether a result concerns leaves or powder, the supplied extract or the finished topical formula.

Water and loss on drying are not automatically the same result

The guideline discusses moisture-related acceptance criteria and notes that a loss-on-drying procedure may be adequate in some circumstances. For preparations containing essential oil, a method specific for water can be needed. A record labelled “loss on drying” should therefore retain that label and method rather than be automatically renamed “water content”.

For a mugwort-related ingredient, first identify the actual preparation and the test performed. A numerical result without that context does not establish which material was lost during the measurement. Nor can a result for dried botanical material simply replace a result for an extract that contains solvents or added excipients.

Particle-size evidence belongs to its specimen

The preparation section discusses particle size for relevant cut or powdered materials and extracts, with appropriate procedures and acceptance criteria when particle size significantly affects relevant properties. It does not assign one universal particle-size limit to every herbal ingredient.

Keep the measured material in the report. A result for a powder before formulation is not automatically a measurement of particles remaining in a balm. A result for an extract does not by itself describe globules in an emulsion. The earlier physical-structure section explains why those objects need separate interpretation.

Sensory characters are part of a description

The source includes organoleptic characters where characteristic. A stated colour, odour or appearance can help describe the preparation under review. It should remain attributed to that material, rather than be transferred into a promise about the smell or skin feel of a finished product containing other ingredients.

A usable comparison therefore keeps the botanical definition, preparation composition, physical tests and finished-product observations in their own fields. The purpose is to compare like measurements and identify real gaps, not to reward the offer with the longest list of unexplained numbers.

20. A complete ingredient declaration and complete chemical characterisation are different tasks

A formula declaration identifies the materials intentionally used to make a product. A botanical preparation can itself contain a complex mixture of chemical constituents. Asking for the complete ingredient declaration therefore does not mean that every molecule in a plant preparation has already been isolated and named.

The FDA’s 2016 Botanical Drug Development guidance, section VII.B, discusses this analytical difficulty. It describes complementary methods, constituent profiles and mass-balance information in the context of botanical drug development. The discussion does not remove the need to declare the actual materials used in a reference balm or coating.

Read which chemical information a method supplies

The guidance recommends evaluating suitable current and emerging analytical technologies and using complementary approaches to identify and quantify active or other chemical constituents. Where the active constituents are unknown and the mixture cannot be fully characterised, it discusses a characteristic profile sensitive to relevant raw-material or manufacturing changes.

A profile is therefore selected for a defined analytical purpose. It is not a substitute for naming an intentionally added oil, adhesive, carrier or other formulation ingredient. Conversely, a recipe naming those ingredients does not provide the analytical profile of every botanical preparation within them.

Weight and chromatographic area have different reporting bases

The source lists several forms of chemical information for consideration, including amounts by weight of known constituents, total amounts within chemical classes, area percentages and relative retention times of unknown quantifiable peaks. These are separate reporting quantities.

When reading a dossier, retain those bases. A chromatographic area percentage should not simply be rewritten as the same percentage by mass in the finished balm. An amount assigned to a class of constituents is not necessarily an identification of every individual molecule within that class. The report’s method and supported relationship determine what can be concluded.

The guidance’s examples of class-level information include lipids and fatty acids, amino acids, carbohydrates and other composition measures where appropriate. Their inclusion in a botanical-drug discussion does not prescribe an identical panel for every topical product. The actual material and purpose remain relevant.

Mass balance concerns the material accounted for

The FDA discusses using data from multiple analytical procedures to demonstrate mass balance among chemical classes and, where appropriate, constituents within a class. This is a broader compositional account than one selected marker result. It does not allow an unidentified remainder to be labelled automatically as mugwort or as a clinically active fraction.

For an actual report, ask what material the balance concerns, which quantities were measured and how the methods fit together. If the source reports only a selected constituent, preserve that limited result. If it provides a broader account, do not reduce it to the largest convenient percentage while omitting the basis.

Keep the two levels together in the identity file

The formulation record and analytical record can support each other while remaining distinct. One identifies what was intentionally combined; the other characterises the relevant material using defined methods. Neither should be used to conceal a missing field in the other.

For the reference products, the appropriate request is the actual declared formula and preparation information, followed by analytical evidence relevant to the question being resolved. This makes the identity review specific without demanding an invented all-molecule certificate or treating an undefined “herbal complex” as a complete declaration.